Palo Alto Investors’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735K | Hold |
445,434
| – | – | 0.16% | 40 |
|
|
2025
Q1 | $704K | Hold |
445,434
| – | – | 0.13% | 38 |
|
|
2024
Q4 | $1.49M | Hold |
445,434
| – | – | 0.23% | 31 |
|
|
2024
Q3 | $837K | Hold |
445,434
| – | – | 0.11% | 37 |
|
|
2024
Q2 | $878K | Hold |
445,434
| – | – | 0.1% | 35 |
|
|
2024
Q1 | $1.37M | Hold |
445,434
| – | – | 0.15% | 34 |
|
|
2023
Q4 | $1.04M | Buy |
+445,434
| New | +$1.04M | 0.09% | 29 |
|